top of page


Atavistik Bio and Roche sign allosteric drug discovery collaboration worth up to $1.9bn
The collaboration gives Roche access to Atavistik Bio's AMPS platform to discover allosteric small molecules across cardiovascular, renal and metabolic disease targets.

nuaxia
Sep 281 min read


Sun Pharma licenses global rights to LIB Therapeutics' cholesterol drug lerodalcibep
The agreement gives Sun Pharma rights to the once-monthly PCSK9 inhibitor lerodalcibep across global markets excluding the US and China.

nuaxia
Sep 281 min read


FDA approves Lerochol autoinjector and updates indication for monthly PCSK9 therapy
The new device provides adults with hypercholesterolaemia with an additional self-administration option for once-monthly Lerochol alongside the existing pre-filled syringe.

nuaxia
Aug 192 min read
bottom of page